HitGen has developed a widespread range of capabilities for drug discovery in DNA-encoded library technology, fragment-based drug design, chemistry, biosciences, computational sciences and informatics, structural biology, clinical trial enabling studies and clinical development, which could support critical stages of drug discovery and development and has the capacity to deliver high quality technical services to meet different needs.

Relying on our capabilities in the discovery and development of potential candidates, HitGen has developed its own pipeline which has produced several novel compounds in clinical trial. With the capability and capacity of taking target from concept to candidate, HitGen is able to deliver both flexible stand-alone solution and integrated drug discovery service for our partners all over the world.